Pharmacologic modulation of reduced glutathione circadian rhythms with buthionine sulfoximine: Relationship with cisplatin toxicity in mice

Toxicology and Applied Pharmacology

Volumn 143, Issue 2, 1997, Pages 281-290

  Li, Xiao Mei ^a   Metzger, Gerard ^a   Filipski, Elisabeth ^a   Boughattas, Naceur ^a   Lemaigre, Guy ^b   Hecquet, Bernard ^c   Filipski, Jan ^d   Levi, Francis ^a  

^a HÔPITAL PAUL BROUSSE   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c CENTRE OSCAR LAMBRET   (France)

^d INSTITUT JACQUES MONOD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BUTHIONINE SULFOXIMINE; CISPLATIN; GLUTATHIONE;

ANIMAL EXPERIMENT; ARTICLE; CIRCADIAN RHYTHM; COLON; CONTROLLED STUDY; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; JEJUNUM; KIDNEY; LEUKOPENIA; LIVER; MALE; MOUSE; NONHUMAN; SURVIVAL; TISSUE LEVEL;

EID: 0030967151     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.8088     Document Type: Article

References (42)

1. Andrews P. A., Howell S. B. Cellular pharmacology of cisplatin: Perspectives on mechanisms of acquired resistance. Cancer Cells. 2:1990;35-43.
2. Behrens B. C., Hamilton T. C., Masuda H. Characterization of a cis-diamminedichloroplatinum (II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res. 47:1987;414-418.
3. Belanger P. M. Chronobiological variation in the hepatic elimination of drugs and toxic chemical agents. Annual Review of Chronopharmacology. 1987;Pergamon Press, New York. p. 1-46.
4. Belanger P. M., Desgagne M., Bruguerolle B. Circadian periodicity in the glutathione concentration of rat liver. Reinberg A., Smolensky M., Labrecque G. Annual Review of Chronopharmacology. 1988;215-218 Pergamon Press, New York.
5. Belanger P. M., Desgagne M., Bruguerolle B. Temporal variation in microsomal lipid peroxidation and in glutathione concentration of rat liver. Drug Metab. Dispos. 19:1991;241-244.
6. Boughattas N. A., Lévi F., Hecquet B., Lemaigre G., Roulon A., Fournier C., Reinberg A. Circadian time dependence of murine tolerance for carboplatin. Toxicol. Appl. Pharmacol. 96:1988;233-247.
7. Boughattas N. A., Lévi F., Fournier C., Lemaigre G., Roulon A., Hecquet B., Mathé G., Reinberg A. Circadian rhythm in toxicities and tissue uptake of oxaliplatin in mice. Cancer Res. 49:1989;3362-3368.
8. Boughattas N. A., Lévi F., Fournier C., Hecquet B., Lemaigre G., Roulon A., Mathé G., Reinberg A. Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice. J. Pharmacol. Exp. Ther. 255:1990;672-679.
9. Boughattas N. A., Hecquet B., Fournier C., Bruguerolle B., Trabelsi H., Bouzouita K., Omrane B., Lévi F. Comparative pharmacokinetics of oxaliplatin (l-OHP) and carboplatin (CBDCA) in mice with reference to circadian dosing time. Biopharmac. Drug Dispos. 15:1994;864.1-864.13.
10. Cotgreave I. A., Schuppekoistinen I. A role for gamma-glutamyl tranpeptidase in the transport of cystine into human endothelial cells: Relationship to intracellular glutathione. Biochim. Biophysica Acta Mol. Cell Res. 1222:1994;375-382.
11. Dusre L., Minnaugh E. G., Myers C. E., Sinha B. K. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumor cells. Cancer Res. 49:1989;511-515.
12. Godwin A. K., Meister A., O'Dwyer P. J., Huang C. S., Hamilton T. C., Andersson M. E. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc. Natl. Acad. Sci. USA. 89:1992;3070-3074.
13. Griffith O. W., Meister A. Glutathione: Interorgan translocation, turnover, and metabolism. Proc. Natl. Acad. Sci. USA. 76:1979;5606-5610.
14. Griffith O. W., Meister A. Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine. J. Biol. Chem. 254:1987;7558-7560.
15. Griffith O. W. L-Buthionine-SR-sulfoximine: Mechanism of action, resolution of diastereomers and as a chemotherapeutic agent. Taniguchi, Higashi, Sakamoto, Meister. Glutathione Centennial. 1989;285-299 Academic Press, San Diego.
16. Hall J. Tripping along the trail to the molecular mechanisms of biological clock. Trends Neurosci. 18:1995;230-240.
17. Hamilton T. C., Winker M. A., Louie K. G., Batist G., Behrens B. C., Tsuruo T., Grotzinger K. R., Mckoy W. M., Young R. C., Ozols R. F. Augmentation of adriamycin, melphalan and cisplatin cytotoxicity in drug (resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. Biochem. Pharmacol. 34:1985;2583-2586.
18. 6. Cancer Chemother. Pharmacol. 11:1983;177-181.
19. Hoffman J., Hardeland R. Diurnal rhythmicity in rat kidney γ-glutamyl transpeptidase activity. Arch. Int. Physiol. Biochim. 89:1981;245-247.
20. Hrushesky W., Lévi F., Halberg F., Kennedy B. J. Circadian stage dependence of cis-diammine dichloroplatinum lethal toxicity in rats. Cancer Res. 42:1982;945-949.
21. Jaeger R. J., Conelly R., Murphy S. Diurnal variation of hepatic glutathione concentration and its correlation with 1-1 dichloro-ethylene inhalation toxicity in rats. Res. Commun. Chem. Pathol. Pharmacol. 6:1973;465-471.
22. Jaeschke H., Wendel A. Diurnal fluctuation and pharmacological alteration of mouse organ glutathione content. Biochem. Pharmacol. 34:1985;1029-1033.
23. Klein D. C., Moore R. Y., Reppert S. M. Suprachiasmatic nucleus. The Mind's Clock. 1991;Oxford University Press, New York/Oxford.
24. Konopka R. J., Benzer S. Clock mutants of Drosophila Melanogaster. Proc. Natl. Acad. Sci. USA. 58:1971;2112-2116.
25. Lévi F., Hrushesky W., Blomquist J., Lakatua D., Haus E., Halberg F., Kennedy B. J. Reduction of cis-diamine dichloroplatinum nephrotoxicity in rats by optimal circadian drug timing. Cancer Res. 42:1982a;950-955.
26. Lévi F., Hrushesky W., Halberg F., Langevin T. R., Haus E., Kennedy B. J. Lethal nephrotoxicity and hematologic toxicity of cis-diammine dichloroplatinum ameliorated by optimal circadian timing and hydration. Eur. J. Cancer Clin. Oncol. 18:1982b;471-477.
27. Lévi F., Mechkouri M., Roulon A., Bailleul F., Lemaigre G., Reinberg A., Mathé G. Circadian rhythm in tolerance of mice for the new anthracycline analog 4′-O-tetrahydropyranyl-adriamicin. Eur. J. Cancer Clin. Oncol. 21:1985;1245-1251.
28. Lévi F., Blazsek I., Ferle-Vidovic A. Circadian and seasonal rhythms in murine bone marrow colony forming cells affect tolerance for the anticancer agent 4′-tetrahydropyranyl Adriamycin (THP). Exp. Hematol. 16:1988;696-701.
29. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin Phenol reagent. J. Biol. Chem. 193:1951;265-275.
30. Meijer C., Mulder N. H., Timmer-Bosscha H., Sluiter W. J., Meersma G. J., de Vries E. G. E. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds. Cancer Res. 52:1992;6885-6889.
31. Meister A., Anderson M. E. Glutathione. Annu. Rev. Biochem. 52:1983;711-760.
32. Mormont M. C., Levi F. Circadian system alterations during cancer processes: A review. Int J. Cancer. 1997.
33. Nakano S., Gemba M. Potentiation of cisplatin-induced lipid peroxidation in kidney cortical slices by glutathione depletion. Jpn. J. Pharmacol. 50:1989;87-92.
34. Nelson W., Tong Y., Lee J. K., Halberg F. Methods for cosinor rhythmometry. Chronobiologia. 6:1979;305-323.
35. Potter D. W., Tran T.-B. Apparent rates of glutathione turnover in rat tissues. Toxicol. Appl. Pharmacol. 120:1993;186-192.
36. Shaw J. P., Chou I. N. Elevation of intracellular glutathione content associated with mitogenic stimulation of quiescent fibroblasts. J. Cell Physiol. 129:1986;193-198.
37. Smaaland R., Svardal A. M., Lote K., Ueland P. M., Laerum O. D. Glutathione content in human bone marrow and circadian stage relation to DNA synthesis. J. Natl. Cancer Inst. 83:1991;1092-1098.
38. Smaaland R., Abrahamsen J. F., Svardal A. M., Lote K., Ueland P. M. DNA cell cycle distribution and glutathione (GSH) content according to circadian stage in bone marrow of cancer patients. Br. J. Cancer. 66:1992;39-45.
39. Somfai-Relles S., Suzukake K., Vistica B. P., Vistica D. T. Reduction in cellular glutathione by buthionine sulfoximine and sensitization of murine tumor cells resistant to L-phenylalanine mustard. Biochem. Pharmacol. 33:1984;485-490.
40. Svardal A. M., Mansoor M. A., Ueland P. M. Determination of reduced, oxydized, and protein-bound glutathione in human plasma with precolumn derivatization with monobromobimane and liquid chromatography. Anal. Biochem. 184:1990;338-346.
41. Tunon M. J., Gonzalez P., Lopez P., Salido G. M., Madrid J. A. Circadian rhythms in glutathione and glutathione-S transferase activity of rat liver. Arch. Int. Physiol. Biochim. Biophys. 100:1992;83-87.
42. White B. P., Davies M. H., Schnell R. C. Circadian variation in hepatic glutathione content, gamma-glutamylcysteine synthetase and gamma-glutamyl transferase activities in mice. Toxicol. Lett. 35:1987;217-223.